Adalta Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.13M | Sell |
18,572
-50
| -0.3% | -$2.92K | 0.54% | 38 |
|
|
2025
Q4 | $1M | Hold |
18,622
| – | – | 0.45% | 36 |
|
|
2025
Q3 | $840K | Sell |
18,622
-150
| -0.8% | -$7K | 0.38% | 39 |
|
|
2025
Q2 | $869K | Buy |
18,772
+50
| +0.3% | +$2.45K | 0.44% | 36 |
|
|
2025
Q1 | $1.14M | Sell |
18,722
-100
| -0.5% | -$5.83K | 0.61% | 33 |
|
|
2024
Q4 | $1.06M | Sell |
18,822
-55
| -0.3% | -$3.07K | 0.56% | 35 |
|
|
2024
Q3 | $977K | Hold |
18,877
| – | – | 0.5% | 35 |
|
|
2024
Q2 | $784K | Hold |
18,877
| – | – | 0.43% | 40 |
|
|
2024
Q1 | $1.02M | Sell |
18,877
-50
| -0.3% | -$2.55K | 0.57% | 33 |
|
|
2023
Q4 | $971K | Sell |
18,927
-165
| -0.9% | -$8.66K | 0.59% | 33 |
|
|
2023
Q3 | $1.11M | Sell |
19,092
-135
| -0.7% | -$8.27K | 0.76% | 32 |
|
|
2023
Q2 | $1.23M | Sell |
19,227
-71
| -0.4% | -$4.76K | 0.82% | 31 |
|
|
2023
Q1 | $1.34M | Hold |
19,298
| – | – | 0.94% | 28 |
|
|
2022
Q4 | $1.39M | Hold |
19,298
| – | – | 0.98% | 27 |
|
|
2022
Q3 | $1.37M | Hold |
19,298
| – | – | 0.99% | 27 |
|
|
2022
Q2 | $1.5M | Hold |
19,298
| – | – | 0.97% | 25 |
|
|
2022
Q1 | $1.42M | Hold |
19,298
| – | – | 0.71% | 31 |
|
|
2021
Q4 | $1.2M | Hold |
19,298
| – | – | 0.55% | 32 |
|
|
2021
Q3 | $1.15M | Hold |
19,298
| – | – | 0.64% | 30 |
|
|
2021
Q2 | $1.29M | Hold |
19,298
| – | – | 0.7% | 29 |
|
|
2021
Q1 | $1.23M | Buy |
19,298
+250
| +1% | +$15.6K | 0.71% | 29 |
|
|
2020
Q4 | $1.19M | Hold |
19,048
| – | – | 0.75% | 30 |
|
|
2020
Q3 | $1.15M | Sell |
19,048
-50
| -0.3% | -$3.01K | 0.84% | 26 |
|
|
2020
Q2 | $1.12M | Hold |
19,098
| – | – | 0.89% | 27 |
|
|
2020
Q1 | $1.06M | Sell |
19,098
-1,000
| -5% | -$61.1K | 0.97% | 28 |
|
|
2019
Q4 | $1.29M | Sell |
20,098
-175
| -0.9% | -$10K | 0.81% | 31 |
|
|
2019
Q3 | $1.03M | Hold |
20,273
| – | – | 0.68% | 35 |
|
|
2019
Q2 | $919K | Hold |
20,273
| – | – | 0.6% | 35 |
|
|
2019
Q1 | $967K | Hold |
20,273
| – | – | 0.73% | 35 |
|
|
2018
Q4 | $1.05M | Sell |
20,273
-275
| -1% | -$14.8K | 0.98% | 29 |
|
|
2018
Q3 | $1.28M | Hold |
20,548
| – | – | 0.91% | 33 |
|
|
2018
Q2 | $1.14M | Sell |
20,548
-600
| -3% | -$32.4K | 0.8% | 33 |
|
|
2018
Q1 | $1.34M | Hold |
21,148
| – | – | 1.02% | 29 |
|
|
2017
Q4 | $1.29M | Sell |
21,148
-685
| -3% | -$42.8K | 0.99% | 31 |
|
|
2017
Q3 | $1.39M | Sell |
21,833
-1,450
| -6% | -$84.7K | 1.14% | 31 |
|
|
2017
Q2 | $1.3M | Hold |
23,283
| – | – | 1.05% | 33 |
|
|
2017
Q1 | $1.27M | Buy |
+23,283
| New | +$1.28M | 1.07% | 32 |
|
Other funds holding BMY
VCM
VPM
Adalta Capital Management's BMY Position: Q1 2026 in Review
Adalta Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 0.27% in Q1 2026, selling an estimated $2.92K and leaving 18,572 shares worth $1.13M. The position accounts for 0.54% of the portfolio, ranked #38.
Adalta Capital Management first reported a position in BMY in Q1 2017 and has held it in 37 quarters since. The position peaked at $1.5M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Adalta Capital Management held 18,572 shares of Bristol-Myers Squibb worth $1.13M as of Q1 2026.
- Adalta Capital Management sold 50 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.92K.
- Bristol-Myers Squibb made up 0.54% of Adalta Capital Management's portfolio in Q1 2026, its #38 holding.
- Adalta Capital Management first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 37 quarters since.
- Adalta Capital Management's Bristol-Myers Squibb position peaked at $1.5M in Q2 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Adalta Capital Management's 13F filing for Q1 2026, filed 18 May 2026.